← All briefs

Agewell Brief Clear signals. Better questions.

Get tomorrow’s edition

FARS-1/FARSA: A tRNA Synthetase That Silences Mitochondrial dsRNAs to Extend Lifespan

Original reporting: Phenylalanyl-tRNA synthetase FARS-1/FARSA balances longevity and immunity by downregulating endogenous mitochondrial double-stranded RNAs.

On the frontier: Regeneration, Quantum biology

A moonlighting enzyme suppresses immunogenic mitochondrial double-stranded RNAs, balancing longevity and innate immunity in worms and human cells.

Three things to remember

  • Mitochondrial dsRNAs accumulate with age and trigger aberrant immune activation.
  • FARS-1/FARSA binds dsRNAs via a novel domain, reducing their levels.
  • Inhibiting FARS-1 boosts immunity but may trade off longevity.

Source

This signal is based on Phenylalanyl-tRNA synthetase FARS-1/FARSA balances longevity and immunity by downregulating endogenous mitochondrial double-stranded RNAs. from PubMed. Read the original report for full context.

Health note: Findings in C. elegans and cultured human cells; human translation unproven.